Golden State Medical Supply Methocarbamol Tablets Recall

Why it was recalled

Presence of Foreign Substance: Presence of hair.

Product description

METHOCARBAMOL TABLETS, USP 500 mg, 500 Count Bottles, Rx Only. Manufactured by AustarPharma LLC, Edison, NJ 08837, USA, Packaged by GSMS Incorporated, Camarillo, CA 93012, USA, NDC: 60429-118-05.

Lot numbers, UPCs & expiration codes

Lot # GS007849, Expiry: 02/2017

Where it was sold

U.S. Including: GA.

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-1426-2015
Classification: Class III
Status: Terminated
Recall initiated: Aug 11, 2015
FDA report date: Sep 16, 2015
Quantity: 1,165 Bottles
Recall type: Voluntary: Firm initiated
Recalling firm: Golden State Medical Supply Inc.

Original FDA data

Every field from FDA enforcement report D-1426-2015, exactly as published.

Show all FDA fields

City: Camarillo
State: CA
Status: Terminated
Country: United States
Event ID: 71921
Address: 5187 Camino Ruiz
Code information: Lot # GS007849, Expiry: 02/2017
Postal code: 93012-8601
Report date: Sep 16, 2015
Product type: Drugs
Recall number: D-1426-2015
Classification: Class III
Recalling firm: Golden State Medical Supply Inc.
Product quantity: 1,165 Bottles
Termination date: Nov 27, 2015
Reason for recall: Presence of Foreign Substance: Presence of hair.
Voluntary / mandated: Voluntary: Firm initiated
Product description: METHOCARBAMOL TABLETS, USP 500 mg, 500 Count Bottles, Rx Only. Manufactured by AustarPharma LLC, Edison, NJ 08837, USA, Packaged by GSMS Incorporated, Camarillo, CA 93012, USA, NDC: 60429-118-05.
Distribution pattern: U.S. Including: GA.
Recall initiation date: Aug 11, 2015
Initial firm notification: Letter
Center classification date: Sep 9, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1426-2015, published Sep 16, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.